NEW YORK, Feb. 26, 2014 /PRNewswire/ --
Emeritus Corporation
Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Emeritus Corporation ("Emeritus") (ESC) to Brookdale Senior Living Inc. for 0.95 shares of Brookdale common stock or transaction value totaling $2.8 billion, with the inclusion of $1.4 billion of Emeritus mortgage debt.
Lifshitz & Miller's investigation is focused on whether the Emeritus directors are acting in shareholders' best interest.
For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.
Nu Skin Enterprises, Inc.
Lifshitz & Miller announces that a class action was filed in the United States District Court for the District of Utah, alleging that Nu Skin Enterprises, Inc. ("Nu Skin") (NUS) issued false and misleading statements to investors between July 10, 2013 through January 16, 2014 by failing to disclose that the Company's operations in the People's Republic of China ("PRC") resulted in pyramid selling schemes in violation of PRC law.
For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.
The Medicines Company
Lifshitz & Miller announces that a class action was filed in the United States District Court for the District of New Jersey, alleging that The Medicines Company ("Medicines") (MDCO) issued false and misleading statements to investors between February 20, 2013 and February 12, 2014, inclusive by failing to disclose that the Company's clinical trials for Cangrelor were unethically and inappropriately administered.
For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.
Thoratec Corporation
Lifshitz & Miller announces that a class action was filed in the United States District Court for the Northern District of California, alleging that Thoratec Corporation ("Thoratec") (THOR) issued false and misleading statements to investors between April 29, 2010 and November 27, 2013, inclusive by failing to disclose that Company's HeartMate II Left Ventricular Assist Device had significant risk of pump thrombosis causing numerous fatalities.
For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.
TriQuint Semiconductor, Inc.
Lifshitz & Miller announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of TriQuint Semiconductor, Inc. ("TriQuint") (TQNT) to RF Micro Devices, Inc. in a stock transaction with an implied price of $9.73 for each TriQuint share.
Lifshitz & Miller's investigation is focused on whether the proposed deal provides adequate value to TriQuint shareholders.
For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by sending an e-mail including your contact information to: info@jlclasslaw.com.
Lifshitz & Miller is a New York based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please visit our website at www.jlclasslaw.com.
ATTORNEY ADVERTISING. © 2014 Lifshitz & Miller. The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com
SOURCE Lifshitz & Miller Law Firm
